Phaseline

Companies › Chongqing Peg-Bio Biopharm

Chongqing Peg-Bio Biopharm: clinical trials, targets and expected readouts

5 active drug programs in 6 registered trials: 4 Phase 1, 1 Phase 3, 1 Phase 2; Gastroenterology, Oncology, Metabolic and endocrine, Hematology; next expected readout Feb 2027.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
PJ009
Glucagon-like peptide-2 (GLP-2) receptor agonist
GLP2RPhase 3Short Bowel SyndromeMar 2027
FT1–Phase 2Short Bowel SyndromeApr 2027
PA5
Pegylated Arginine Deiminase Dimer
ADI1Phase 1Advanced Solid TumorsFeb 2027
PL54
PEGylated recombinant phenylalanine ammonia-lyase
PAHPhase 1Phenylketonuria (PKU)Jun 2027
PN20
thrombopoietin receptor agonist
THPOPhase 1Primary Immune Thrombocytopenia (ITP); Thrombocytopenia Associated With Chronic Liver Disease–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT06880081PN20Phase 1Primary Immune Thrombocytopenia (ITP)HematologyFeb 2026
NCT07446491PN20Phase 1Thrombocytopenia Associated With Chronic Liver DiseaseHematologyOct 2026
NCT07702162PA5Phase 1Advanced Solid TumorsOncologyFeb 2027
NCT06512584PJ009Phase 3Short Bowel SyndromeGastroenterologyMar 2027
NCT07704047FT1Phase 2Short Bowel SyndromeGastroenterologyApr 2027
NCT07672756PL54Phase 1Phenylketonuria (PKU)Metabolic and endocrineJun 2027

Targets

ADI1 (1) PAH (1) GLP2R (1) THPO (1)

Companies with the same targets

BioMarin Pharmaceutical PTC Therapeutics NGGT Agios Pharmaceuticals NGGT (Suzhou) Biotechnology VectivBio Takeda Geropharm MIBIO PTE. Sichuan Clover Biopharmaceuticals

Companies built like this

Ipsen VectivBio Zhejiang Doer Biologics Dong-A ST Hanmi Pharmaceutical Company

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.